CN114869840B - Prebiotic face cream and preparation method thereof - Google Patents
Prebiotic face cream and preparation method thereof Download PDFInfo
- Publication number
- CN114869840B CN114869840B CN202210640211.6A CN202210640211A CN114869840B CN 114869840 B CN114869840 B CN 114869840B CN 202210640211 A CN202210640211 A CN 202210640211A CN 114869840 B CN114869840 B CN 114869840B
- Authority
- CN
- China
- Prior art keywords
- parts
- prebiotic
- preparation
- oligosaccharide
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 115
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 111
- 239000006071 cream Substances 0.000 title claims abstract description 64
- 239000006041 probiotic Substances 0.000 claims abstract description 71
- 239000000203 mixture Substances 0.000 claims abstract description 70
- 239000000419 plant extract Substances 0.000 claims abstract description 68
- 235000018291 probiotics Nutrition 0.000 claims abstract description 67
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 41
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 38
- 230000000529 probiotic effect Effects 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 18
- 239000008158 vegetable oil Substances 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 239000011159 matrix material Substances 0.000 claims abstract description 7
- 239000008367 deionised water Substances 0.000 claims abstract description 6
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 6
- 238000004945 emulsification Methods 0.000 claims abstract description 4
- 238000000855 fermentation Methods 0.000 claims description 40
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 37
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 37
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 37
- 239000006166 lysate Substances 0.000 claims description 32
- 230000004151 fermentation Effects 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 30
- 239000001963 growth medium Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 17
- 238000000926 separation method Methods 0.000 claims description 17
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 15
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 14
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 235000013405 beer Nutrition 0.000 claims description 10
- 235000020247 cow milk Nutrition 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 8
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 7
- 229940106157 cellulase Drugs 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 7
- 238000003825 pressing Methods 0.000 claims description 7
- 238000005292 vacuum distillation Methods 0.000 claims description 7
- 238000010564 aerobic fermentation Methods 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 5
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 5
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 5
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 5
- 239000008169 grapeseed oil Substances 0.000 claims description 5
- 238000011218 seed culture Methods 0.000 claims description 5
- 229940057910 shea butter Drugs 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 3
- 241000168525 Haematococcus Species 0.000 claims description 3
- 235000004347 Perilla Nutrition 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 claims description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 3
- 241000405414 Rehmannia Species 0.000 claims description 3
- 244000275012 Sesbania cannabina Species 0.000 claims description 3
- 230000001815 facial effect Effects 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 240000001417 Vigna umbellata Species 0.000 claims description 2
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 62
- 230000006872 improvement Effects 0.000 abstract description 10
- 238000013329 compounding Methods 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 description 77
- 210000003491 skin Anatomy 0.000 description 70
- 230000000694 effects Effects 0.000 description 61
- 239000000243 solution Substances 0.000 description 22
- 241000186427 Cutibacterium acnes Species 0.000 description 20
- 241000191967 Staphylococcus aureus Species 0.000 description 20
- 229940055019 propionibacterium acne Drugs 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 19
- 238000005259 measurement Methods 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 11
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 10
- 239000004530 micro-emulsion Substances 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 230000009286 beneficial effect Effects 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000607479 Yersinia pestis Species 0.000 description 8
- 238000011056 performance test Methods 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- 239000006872 mrs medium Substances 0.000 description 5
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 235000019871 vegetable fat Nutrition 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- 208000020154 Acnes Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 241000213948 Astragalus sinicus Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The application relates to the technical field of daily cosmetics, in particular to prebiotic face cream and a preparation method thereof. The prebiotic face cream consists of a prebiotic composition and a matrix formula; the prebiotic composition comprises the following components in parts by weight: 50-60 parts of functional oligosaccharide, 8-12 parts of probiotic components, 8-12 parts of plant extracts, 3-5 parts of emulsification aids, 20-30 parts of deionized water and 15-20 parts of vegetable oil; the prebiotic composition is prepared by ultrasonic mixing. The improvement of the skin surface microecology is realized through the compounding of the prebiotic-functional oligosaccharide, the implanted probiotic-probiotic component and the plant extract, and compared with the single use of the prebiotic component, the probiotic-functional oligosaccharide is favorable for replacing harmful bacteria by the auxiliary probiotic, so that the auxiliary probiotic occupies the dominant position of the skin surface microecology.
Description
Technical Field
The application relates to the technical field of daily cosmetics, in particular to prebiotic face cream and a preparation method thereof.
Background
The cream is a cream-like texture skin care product special for facial skin, can effectively improve various problems of the skin, nourish and protect the skin deeply, and in recent years, along with the pursuit of higher effect of the cream by people, the prebiotic cream capable of improving microecology of the skin surface is generated.
The prebiotics in the related art mainly comprise beta-glucan, fructo-oligosaccharide, xylo-oligosaccharide, galacto-oligosaccharide, isomaltooligosaccharide and other functional oligosaccharides and matrix formulas, and can provide growing food for beneficial bacteria on the skin through the functional oligosaccharides after being coated on the face, so that the growth and breeding of the beneficial bacteria are promoted while moisturizing, repairing and nourishing the skin.
However, the repairing and nourishing effects of the prebiotic face cream are generally limited by the original colony condition of the skin and the interference of external adverse factors, and when the skin environment is changed due to excessive cleaning, antibiotics, ultraviolet rays, lack of nutrition, coldness and other factors, the number of probiotics can be obviously reduced;
and because the prebiotics do not have specificity, when the probiotics and the harmful bacteria are seriously unbalanced, and the harmful bacteria take the dominant place and invade the microecology on the skin surface, the prebiotics can be absorbed by the harmful bacteria, and further propagation of the harmful bacteria is promoted, so that vicious circulation is generated.
Disclosure of Invention
In order to solve the problems, and reduce the risk of further propagation of harmful bacteria and vicious circle caused by unbalanced flora and ingestion of the prebiotics by the harmful bacteria, the application particularly provides the prebiotic cream and a preparation method thereof.
In a first aspect, the present application provides a prebiotic cream, which adopts the following technical scheme:
a prebiotic facial cream comprises prebiotic composition and matrix formula;
the prebiotic composition comprises the following components in parts by weight:
50-60 parts of functional oligosaccharide, 8-12 parts of probiotic components, 8-12 parts of plant extracts, 3-5 parts of emulsification aids, 20-30 parts of deionized water and 15-20 parts of vegetable oil;
the preparation method comprises the following steps:
a1, firstly mixing functional oligosaccharide with deionized water according to corresponding parts by weight, and preheating at 40-60 ℃ to obtain a phase A;
a2, mixing the probiotic components, the plant extracts and the vegetable oil according to the corresponding parts by weight at 30-40 ℃ to obtain a phase B;
a3, after the A, B phase is cooled to room temperature under vacuum condition, mixing A, B phases, adding an emulsifying aid, and finally carrying out ultrasonic mixing to obtain the prebiotic composition.
By adopting the technical scheme, after the face cream is coated on the skin, the improvement of the skin surface microecology is realized under the compound effect of the prebiotic-functional oligosaccharide, the implanted probiotic-probiotic component and the plant extract, and compared with the single use of the prebiotic component, the face cream is favorable for assisting the probiotic to replace harmful bacteria, so that the probiotic occupies the dominant position of the skin surface microecology;
The obtained prebiotic composition is bicontinuous emulsion, and can form a stable microemulsion system under the action of an emulsification auxiliary agent and ultrasonic conditions, wherein the microemulsion system can wrap the probiotic components on the opposite inner sides of the microemulsion, and the functional oligosaccharides and the plant extracts are distributed on the opposite outer sides of the microemulsion system, so that the loss and activity loss of the functional oligosaccharides and the plant extracts are reduced while the activity of the probiotic components is effectively ensured.
Preferably, the functional oligosaccharide is one or more of fructo-oligosaccharide, xylo-oligosaccharide, galacto-oligosaccharide, isomalto-oligosaccharide, gentio-oligosaccharide, soy oligosaccharide and chitosan oligosaccharide.
By adopting the technical scheme, the functional oligosaccharide consisting of one or more of fructo-oligosaccharide, xylo-oligosaccharide, galacto-oligosaccharide, isomaltooligosaccharide, gentiooligosaccharide, soybean oligosaccharide and chitosan oligosaccharide can be used as basic nutrition supply, so that the growth of probiotics is ensured;
after the emulsion with double continuous phases is prepared, the effect of assisting in forming micro-emulsion can be achieved, the separation and protection effects on the probiotic components are achieved, and meanwhile, the emulsion can also achieve the effects of assisting in forming films and wetting protection after being coated on skin, so that the influence and interference of external adverse factors on probiotics are reduced.
Preferably, the probiotic component is compounded by one or more of lactobacillus gasseri, lactobacillus rhamnosus, bifidobacterium animalis, staphylococcus epidermidis, yeast cell lysate and lactobacillus plantarum lysate.
Preferably, the probiotic component consists of lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and lactobacillus plantarum lysate in a weight ratio of 1 (3-5): 10-20): 8-15.
By adopting the technical scheme, the probiotic component compounded by lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis, yeast cell lysate and lactobacillus plantarum lysate can be used as an implanted external beneficial bacterium, so that the probiotic can replace harmful bacteria, occupy the dominant position of skin surface microecology, and can also obviously improve the living environment of epidermidis;
in addition, lactobacillus gasseri and bifidobacterium animalis used in the application are anaerobic bacteria, and enter injury parts (anaerobic environment and competition with harmful bacteria) such as acne under the action of bicontinuous emulsion, so that the propagation and growth environment of the harmful bacteria is destroyed, and the aim of inhibiting pathogens or the fixed value of the harmful bacteria is fulfilled; and the reproduction and development of staphylococcus epidermidis on the epidermis are not easily affected.
Preferably, the lactobacillus plantarum lysate extraction and lysis method is as follows:
b1, inoculating a slant culture of lactobacillus plantarum CCTCC NO: M2017399 into a seed culture medium, namely an MRS culture medium, and culturing for 8-12 hours under the anaerobic condition of 28-32 ℃ to obtain seed liquid;
b2, transferring the seed liquid well grown in the B1 into a fermentation culture medium according to the inoculum size of 0.5-1.2%, and culturing for 24-36h under the same condition of the B1 to obtain fermentation liquor;
the fermentation culture medium consists of MRS culture medium, cow milk and rye beer in the weight ratio of 1 (0.1-0.3) (0.05-0.10);
b3, centrifuging the fermentation liquor obtained in the step B2 at 8000-12000rpm for 20-30min, and taking supernatant to obtain lactobacillus plantarum lysate, and freeze-drying at-20 ℃ for later use.
By adopting the technical scheme, the lactobacillus plantarum lysate prepared by the extraction process has high content of beneficial proteins, amino acids and other nutrient substances in the lactobacillus plantarum lysate, has remarkable growth promoting effect on the lactobacillus gasseri of the same genus, can inhibit pathogens or harmful bacteria fixed values through the lactobacillus gasseri, and is compounded with forward implantation of staphylococcus epidermidis, so that the purpose that the probiotics replace harmful bacteria and occupy the microecological dominant position on the surface of skin is achieved.
In addition, it is to be noted that: the culture medium used in the application is a special culture medium and is compounded from MRS culture medium, cow milk and rye beer, the adjustment can effectively increase the protein and amino acid content in the final cracking product, and the addition of the rye beer can effectively protect the protein containing sulfhydryl from being oxidized, so that the activity of the obtained protein and amino acid is higher.
Preferably, the plant extract is prepared from one or more of red bean pulp, haematococcus, rehmannia root, walnut kernel, perilla, astragalus sinicus, peach petal, sesbania and radix asparagi.
Preferably, the plant extract is prepared from the following raw materials in parts by weight:
3-5 parts of soybean meal, 5-8 parts of haematococcus, 8-15 parts of rehmannia, 5-8 parts of perilla, 3-5 parts of peach petals, 3-5 parts of sesbania and 8-10 parts of radix asparagi.
By adopting the technical scheme, the plant extract extracted from the raw material components can be compounded with the functional oligosaccharide and the probiotics component to realize the improvement of the microecology on the skin surface, has the epidermis and acne repairing effect and the antibacterial effect, and can effectively destroy the living environment of anaerobic harmful bacteria, thereby promoting the probiotics to quickly replace the harmful bacteria and occupying the dominant position of the microecology on the skin surface.
Preferably, the extraction method of the plant extract comprises the following steps:
c1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3-5 times of volume, performing aerobic fermentation at the pH of 5.0-6.0 and the temperature of 46-52 ℃ for 60-120min, and performing solid-liquid separation on fermentation liquor, and respectively refrigerating filtrate and filter residue for later use;
placing the filter residue obtained in the step C1 into an extracting solution with the volume of 1-2 times, adding cellulase accounting for 2-5%o of the extracting solution and pectase accounting for 1-3%o of the extracting solution, performing anaerobic fermentation for 4-8 hours at the temperature of 40-52 ℃ at the pH of 7-8, performing filter pressing for solid-liquid separation, removing the filter residue, combining the filtrate in the step C1, and performing vacuum distillation for water removal to obtain a plant extract;
wherein the extracting solution in the C2 consists of ethanol, polyglycerol-5 trioleate and ethyl acetate according to the weight ratio of 1 (0.1-0.3) to 0.3-0.5.
By adopting the technical scheme, the plant extract extracted by the process has simple preparation method, the final finished product does not need to remove the extracting solution, the content of effective active substances in the plant extract is high, and the plant extract can be compounded with functional oligosaccharide and probiotics to realize improvement of skin surface microecology and effectively destroy living environment of anaerobic harmful bacteria;
The analysis of the reasons may be two, on the one hand, since the C2 extracting solution is a multiphase extracting solution, the hydrophilic and lipophilic of the effective active substances can be respectively extracted; the second aspect is that the plant extract is treated by adopting a fermentation mode of firstly short-time aerobic and then long-time anaerobic, which provides a good decomposition environment for enzymes and additional enzymes of plants, thereby promoting the dissolution of relevant effective components in plant raw materials.
Preferably, the vegetable oil is one or more of shea butter, sweet almond oil, grape seed oil, sunflower seed oil, white pool seed oil and linseed oil.
By adopting the technical scheme, the vegetable oil compounded by the components can assist the formation of a micro-emulsion system of the bicontinuous phase, so that the vegetable oil can stably store functional substances such as functional oligosaccharide, probiotic components, plant extracts and the like, has a promoting effect on the epidermis of the plant extracts and the repairing and antibacterial effects of acnes, and each component is selected from green natural vegetable oil.
In a second aspect, the present application provides a method for preparing a prebiotic cream, which adopts the following technical scheme:
a preparation method of prebiotic cream comprises the following preparation steps:
Vacuum pouring the prebiotic composition and matrix formulation into emulsifying pot, homogenizing at normal temperature for 5-10min to obtain the final product.
By adopting the technical scheme, the preparation process of the face cream is obviously simplified, special conditions such as heating are not needed, the influence of temperature operation on the performance of the face cream and the prebiotic composition in the face cream is reduced, the performance of the obtained prebiotic face cream is stable and uniform, and the face cream has excellent moisturizing and conditioning effects, so that the face cream has extremely high economic benefit and is suitable for industrialized large-scale production.
In summary, the present application has the following beneficial effects:
1. the improvement effect of the microbial agent on the skin surface is realized by compounding the functional oligosaccharide, the probiotic component and the plant extract, which is beneficial to helping the probiotics to replace harmful bacteria and occupy the dominant position of the microbial agent on the skin surface, so that hidden danger caused by unbalanced flora on the skin surface is reduced;
2. the prebiotic composition exists in the form of bicontinuous emulsion, the emulsion can wrap the probiotic components on the opposite inner sides of the microemulsion, and the functional oligosaccharides and the plant extracts are distributed on the opposite outer sides of the microemulsion system, so that the loss and activity loss of the functional oligosaccharides and the plant extracts are reduced while the activity of the probiotic components is effectively ensured;
3. The probiotic component compounded by lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis, yeast cell lysate and lactobacillus plantarum lysate can be used as an implanted external beneficial bacterium, so that the probiotic can replace harmful bacteria, occupy the dominant position of the microecology on the surface of the skin, and can obviously improve the living environment of epidermidis so as to be unfavorable for the field planting of the harmful bacteria;
4. the preparation process is simplified, heating and other special conditions are not needed, the influence of temperature conditions on the performance of the face cream and the prebiotic composition in the face cream is reduced, and the obtained prebiotic face cream has stable and uniform performance and excellent skin moisturizing and conditioning effects, so that the face cream has extremely high economic benefit and is suitable for industrialized large-scale production.
Detailed Description
The present application will be described in further detail with reference to examples, wherein the raw materials used in the preparation examples and examples of the present application are commercially available common raw materials except for the following specific description;
lactobacillus with a preservation number of CGMCC No.6361;
bifidobacterium animalis with a preservation number of CGMCC No.12942;
staphylococcus epidermidis accession No. ATCC12228.
Preparation example
Preparation examples 1 to 5
The plant extract is prepared from the following raw materials in parts by weight:
c1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3 times of volume, performing aerobic fermentation for 180min at the pH of 5.0 and the temperature of 46 ℃, and performing solid-liquid separation on fermentation liquor, wherein filtrate and filter residue are respectively refrigerated for later use;
c2, placing filter residues obtained in the step C1 into an extracting solution with the volume being 1 times, adding cellulase accounting for 3 permillage and pectase accounting for 2 permillage of the extracting solution, performing anaerobic fermentation for 12 hours under the conditions of pH 7.0 and the temperature of 40 ℃, performing filter pressing for solid-liquid separation, discarding filter residues, combining filtrate in the step C1, and performing vacuum distillation for water removal to obtain a plant extract;
the extracting solution in C2 consists of ethanol, polyglycerol-5 trioleate and ethyl acetate according to the weight ratio of 1:0.2:0.2.
Table: each component of the raw materials and its weight (kg) were extracted in production examples 1 to 5
Preparation example 6
The plant extract differs from preparation example 1 in that the specific preparation steps are as follows:
c1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3 times of volume, performing aerobic fermentation for 120min at the pH of 5.0 and the temperature of 46 ℃, and performing solid-liquid separation on the fermentation liquid, wherein filtrate and filter residues are respectively refrigerated for later use;
And C2, placing filter residues obtained in the step C1 into an extracting solution with the volume being 1, adding cellulase accounting for 3 per mill of the extracting solution and pectase accounting for 2 per mill of the extracting solution, performing anaerobic fermentation for 8 hours at the pH of 7.0 and the temperature of 40 ℃, performing filter pressing for solid-liquid separation, discarding filter residues, combining filtrate in the step C1, and performing vacuum distillation for water removal to obtain the plant extract.
Preparation example 7
The plant extract differs from preparation example 1 in that the specific preparation steps are as follows:
c1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3 times of volume, performing aerobic fermentation for 100min at the pH of 5.5 and the temperature of 48 ℃, and performing solid-liquid separation on fermentation liquor, wherein filtrate and filter residue are respectively refrigerated for later use;
and C2, placing filter residues obtained in the step C1 into an extracting solution with the volume being 1, adding cellulase accounting for 3 per mill of the extracting solution and pectase accounting for 2 per mill of the extracting solution, performing anaerobic fermentation for 6 hours at the pH of 7.5 and the temperature of 46 ℃, performing filter pressing for solid-liquid separation, discarding filter residues, combining filtrate in the step C1, and performing vacuum distillation for water removal to obtain the plant extract.
Preparation example 8
The plant extract differs from preparation example 1 in that the specific preparation steps are as follows:
C1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3 times of volume, performing aerobic fermentation for 60min at the pH of 6.0 and the temperature of 52 ℃, and performing solid-liquid separation on fermentation liquor, wherein filtrate and filter residue are respectively refrigerated for later use;
and C2, placing filter residues obtained in the step C1 into an extracting solution with the volume being 1, adding cellulase accounting for 3 per mill of the extracting solution and pectase accounting for 2 per mill of the extracting solution, performing anaerobic fermentation for 4 hours at the pH value of 8.0 and the temperature of 52 ℃, performing filter pressing for solid-liquid separation, discarding filter residues, combining filtrate in the step C1, and performing vacuum distillation for water removal to obtain the plant extract.
Preparation example 9
A plant extract is different from preparation example 1 in that the extract in C2 consists of ethanol, polyglycerol-5 trioleate and ethyl acetate according to the weight ratio of 1:0.1:0.3.
Preparation example 10
A plant extract is different from preparation example 1 in that the extract in C2 consists of ethanol, polyglycerol-5 trioleate and ethyl acetate in a weight ratio of 1:0.3:0.5.
PREPARATION EXAMPLE 11
A lactobacillus plantarum lysate is prepared by the following steps:
b1, inoculating a slant culture of lactobacillus plantarum CCTCC NO: M2017399 into a seed culture medium, namely an MRS culture medium, and culturing for 12 hours under the anaerobic condition at 32 ℃ to obtain seed liquid;
B2, transferring the seed liquid well grown in the B1 into a fermentation culture medium according to the inoculation amount of 1.0%, and culturing for 30 hours under the same condition of the B1 to obtain a fermentation liquid;
the fermentation medium consists of MRS medium and cow milk in the weight ratio of 1:0.1;
and B3, centrifuging the fermentation liquor obtained in the step B2 at a rotating speed of 10000rpm for 25min, and taking supernatant to obtain lactobacillus plantarum lysate, and freeze-drying at-20 ℃ for later use.
Preparation example 12
Lactobacillus plantarum lysate differs from preparation 11 in that the lysis method is as follows:
b1, inoculating a slant culture of lactobacillus plantarum CCTCC NO: M2017399 into a seed culture medium, namely an MRS culture medium, and culturing for 12 hours under the anaerobic condition at 28 ℃ to obtain seed liquid;
b2, transferring the seed liquid well grown in the B1 into a fermentation culture medium according to the inoculation amount of 1.0%, and culturing for 30 hours under the same condition of the B1 to obtain a fermentation liquid;
and B3, centrifuging the fermentation liquor obtained in the step B2 at a rotating speed of 10000rpm for 25min, and taking supernatant to obtain lactobacillus plantarum lysate, and freeze-drying at-20 ℃ for later use.
Preparation example 13
Lactobacillus plantarum lysate differs from preparation 11 in that the lysis method is as follows:
b1, inoculating a slant culture of lactobacillus plantarum CCTCC NO: M2017399 into a seed culture medium, namely an MRS culture medium, and culturing for 8 hours under the anaerobic condition at 32 ℃ to obtain seed liquid;
B2, transferring the seed liquid well grown in the B1 into a fermentation culture medium according to the inoculation amount of 1.2%, and culturing for 24 hours under the same condition of the B1 to obtain fermentation liquid;
and B3, centrifuging the fermentation liquor obtained in the step B2 at a rotating speed of 10000rpm for 25min, and taking supernatant to obtain lactobacillus plantarum lysate, and freeze-drying at-20 ℃ for later use.
PREPARATION EXAMPLE 14
Lactobacillus plantarum lysate differs from preparation 11 in that the fermentation medium consists of MRS medium, cow's milk and rye beer (3.5 degrees) in a weight ratio of 1:0.1:0.05.
Preparation example 15
Lactobacillus plantarum lysate differs from preparation 11 in that the fermentation medium consists of MRS medium, cow's milk and rye beer (3.5 degrees) in a weight ratio of 1:0.2:0.10.
PREPARATION EXAMPLE 16
Lactobacillus plantarum lysate differs from preparation 11 in that the fermentation medium consists of MRS medium, cow's milk and rye beer (3.5 ℃) in a weight ratio of 1:0.3:0.10.
Preparation example 17
Lactobacillus plantarum lysate differs from preparation 11 in that the fermentation medium consists of MRS medium, cow's milk and rye beer (3.5 ℃) in a weight ratio of 1:0.3:0.20.
PREPARATION EXAMPLE 18
A lactobacillus plantarum lysate is different from preparation example 11 in that the preservation number of lactobacillus plantarum is CGMCC No.11156.
Preparation examples 19 to 26
A prebiotic composition, the components and their respective weights are shown in the following table and is prepared by the following method:
a1, firstly mixing functional oligosaccharide with deionized water at 800r/min for 30min, and preheating at 40 ℃ to obtain a phase A; wherein the functional oligosaccharide consists of fructo-oligosaccharide, chitosan oligosaccharide and isomaltooligosaccharide according to the weight ratio of 1:0.2:1.5;
a2, mixing the probiotic component, the plant extract and the vegetable oil at 30 ℃ for 10min at a rotating speed of 2000r/min to obtain a phase B;
wherein the probiotic component consists of lactobacillus gasseri, bifidobacterium animalis and staphylococcus epidermidis according to the weight ratio of 1:5:8;
the plant extract was prepared in preparation example 1;
the vegetable oil consists of shea butter and grape seed oil according to the weight ratio of 1:2;
a3, after the A, B phase is cooled to room temperature (25 ℃) under vacuum condition, premixing the A phase and the B phase for 5min at 2000r/min, adding an emulsifying aid, and finally carrying out ultrasonic mixing for 20min at the power of 2.0KW and the amplitude of 70um, thus obtaining the prebiotic composition.
Table: the prebiotic composition components and weights (kg) in preparation examples 19-26
Preparation example 27
A prebiotic composition differs from preparation 19 in that the functional oligosaccharide consists of fructo-oligosaccharide, galacto-oligosaccharide, isomalto-oligosaccharide and isomalto-oligosaccharide in a weight ratio of 1:1:0.5:0.3.
PREPARATION EXAMPLE 28
A prebiotic composition differs from preparation 19 in that the functional oligosaccharide consists of fructo-oligosaccharide, xylo-oligosaccharide and isomaltooligosaccharide in a weight ratio of 1:1.2:0.5.
Preparation example 29
A prebiotic composition differs from preparation 19 in that the probiotic composition consists of Lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and Lactobacillus plantarum lysate obtained in preparation 11 in a weight ratio of 1:3:10:8.
Preparation example 30
A prebiotic composition differs from preparation 19 in that the probiotic composition consists of Lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and Lactobacillus plantarum lysate obtained in preparation 11 in a weight ratio of 1:4:12:12.
Preparation example 31
A prebiotic composition differs from preparation 19 in that the probiotic composition consists of Lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and Lactobacillus plantarum lysate obtained in preparation 11 in a weight ratio of 1:5:20:15.
PREPARATION EXAMPLE 32
A prebiotic composition differs from preparation 19 in that the probiotic composition consists of Lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and Lactobacillus plantarum lysate obtained in preparation 11 in a weight ratio of 1:5:5:5.
PREPARATION EXAMPLES 33 to 40
A prebiotic composition differs from preparation 29 in that the Lactobacillus plantarum lysate used in the composition is used in a manner as shown in the following Table.
Table: table for comparing the use cases of Lactobacillus plantarum lysates in preparation examples 33-40
PREPARATION EXAMPLES 41 to 49
A prebiotic composition differs from that of preparation 19 in that the plant extracts used in the components are used differently, and the specific correspondence is shown in the following table.
Table: table comparing usage of plant extracts in preparation examples 41 to 49
Group of | Plant extracts |
PREPARATION EXAMPLE 41 | Prepared from preparation example 2 |
PREPARATION EXAMPLE 42 | Prepared from preparation example 3 |
Preparation example 43 | Prepared from preparation 4 |
PREPARATION EXAMPLE 44 | Prepared from preparation 5 |
PREPARATION EXAMPLE 45 | From preparation 6 |
Preparation example 46 | Prepared from preparation 7 |
Preparation example 47 | Prepared from preparation 8 |
Preparation example 48 | Prepared in preparation example 9 |
Preparation example 49 | Prepared from preparation 10 |
PREPARATION EXAMPLE 50
A prebiotic composition differs from preparation 19 in that the vegetable fat consists of shea butter, grape seed oil and white pond flower seed oil in a weight ratio of 1:2:0.5.
Performance test
The prebiotic creams (100 g/bottle) prepared in each example and comparative example were selected for detection, the subjects were 440 adults aged 25-50 years, 10 persons per group, and the subjects were required to clean the face before applying the prebiotic cream, and the water content of the face was kept at not higher than 20%;
Then, the skin harmful bacteria inhibition rate delta Q% is respectively detected after the application of the skin harmful bacteria inhibition rate delta Q% is carried out three times a day and 1+/-0.2 g each time, and the specific detection steps and reference standards are as follows:
skin pest inhibition rate Δq%:
the face is sampled before test, on the day of smearing and after 30 days of continuous smearing respectively, namely sterile cotton swab soaked by physiological saline is pressed on the face, the sterile cotton swab and the wiping surface are 45 degrees, and then the face is wiped (sampling area is 4cm 2 ) About 30s, and preparing 10ml of sample solution by using normal saline;
then calculating the total number of bacterial colonies in each sample liquid by adopting a plate counting method, and obtaining the inhibition rate delta Q of the skin flora according to the ratio of the total number of the bacterial colonies after coating to the total number of the bacterial colonies before coating, so as to represent the improvement effect of the face cream on the microecology of the skin surface; the skin harmful bacteria are exemplified by staphylococcus aureus and propionibacterium acnes, and the detection results and the evaluation criteria are as follows:
and (3) the following materials: 60< Δq value (considered significant inhibition);
o: 10< Δq <60 (considered inhibitory);
x: Δq <10 (considered to be essentially non-inhibitory).
It should be noted that the main person of the tested person is a person who is a department of me, and after 30 days of continuous coating, the tested person does not return to the test, and the data of the tested person is discarded.
Examples
Examples 1 to 6
The prebiotic cream comprises the following components and the corresponding weights, and is prepared by the following preparation method;
vacuum pouring the prebiotic composition and matrix formulation into 4Kw emulsifying pot, homogenizing at 25deg.C under stirring speed of 80rpm for 10min to obtain the final product.
Wherein the prebiotic composition was prepared from preparation 19.
Table: each component in examples 1 to 6 and its weight (kg)
Comparative example 1
A prebiotic cream differs from example 1 in that the prebiotic composition is only a functional oligosaccharide.
Comparative example 2
A prebiotic cream differs from example 1 in that the prebiotic composition is the only probiotic component.
Comparative example 3
A prebiotic cream differs from example 1 in that the prebiotic composition is only a plant extract.
Comparative example 4
A prebiotic cream, different from example 1, was prepared by mixing the three components at 2000r/min, with the prebiotic composition comprising only functional oligosaccharides, probiotic components and plant extracts.
The prebiotic creams of examples 1-6 and comparative examples 1-4 were extracted and tested for their skin pest inhibition ΔQ according to the above measurement procedure and measurement criteria, and the average value of the test results is shown in the following table.
Table: results of Performance test of skin harmful bacteria inhibition RaQ% of examples 1 to 6 and comparative examples 1 to 4
From the above table, it can be seen that the prebiotic creams prepared in examples 1-6 all have excellent effect of improving skin surface microecology, and the purpose that probiotics occupy the dominant position of skin surface microecology can be achieved by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 32.8-43.8%, and the inhibition rate delta Q% of propionibacterium acnes is 41.2-46.6%, which are regarded as having inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 61.7-82.3% and the inhibition rate delta Q% of propionibacterium acnes is 79.1-89.5% after being continuously smeared for 30 days, and the composition is considered to have obvious inhibition effect.
The improvement of the microecology on the skin surface can be effectively realized through the compounding of the prebiotic-functional oligosaccharide, the implanted probiotic-probiotic component and the plant extract, and compared with the single use of the prebiotic component, the method reduces the risk of further propagation of harmful bacteria caused by unbalanced bacterial colony and ingestion of the prebiotic by the harmful bacteria and generation of vicious circulation.
In addition, as can be seen from the data in examples 1 to 6 of the above table, as the usage amount of the prebiotic composition increases, the effect of improving the microecology on the skin surface increases correspondingly, and when the usage amount of the prebiotic composition is 30 to 50%, the effect of the prebiotic composition approaches saturation, and the usage amount is continuously increased, so that the effect of the prebiotic composition is slightly improved, thus combining the actual production cost and effect, and taking examples 4 to 5 as preferred examples.
Further, as can be seen from comparative examples 1 to 3, the effect of improving the microecology on the skin surface is reduced to different degrees when any one of the prebiotic-functional oligosaccharide, the implanted probiotic-probiotic component and the plant extract is absent; wherein the improvement effect on the skin surface micro-ecology is substantially lost in comparative example 1:
the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 8.1 percent, the inhibition rate delta Q% of propionibacterium acnes is 6.5 percent, and no inhibition effect is considered;
the inhibition rate DeltaQ% of staphylococcus aureus was 7.8% and the inhibition rate DeltaQ% of propionibacterium acnes was 6.1% after continuous application for 30 days, and no inhibition effect was considered.
Comparative examples 2 to 3 only have a certain effect of improving the microecology of the skin surface, and comparative example 3 has better effect of long-term application: the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 11.2-17.2% and the inhibition rate delta Q% of propionibacterium acnes is 18.3-24.5%, which is regarded as having a certain inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 25.8-31.2% and the inhibition rate delta Q% of propionibacterium acnes is 38.2-43.2% after being continuously smeared for 30 days, and the composition has a certain inhibition effect.
Further, as can be seen from comparative example 4, the level of inhibition on the day of application was comparable to that of example 1, but the inhibition rate Δq% of staphylococcus aureus on 30 days of application was only 42.2%, and the inhibition rate Δq% of propionibacterium acnes was only 52.4%, all of which were reduced to different degrees.
It can be seen that only a specific bicontinuous phase emulsion system can ensure the stable improvement effect on the skin surface micro-ecology, and has better use effect compared with the conventional water-in-oil emulsion and oil-in-water emulsion;
the reason for this may be analyzed as follows: functional oligosaccharides are generally hydrophilic, while probiotic components have hydrophobicity and hydrophilicity respectively due to the inclusion of both living bacteria and cleavage products, and the inner components have both hydrophobicity and hydrophilicity as in plant extracts;
therefore, the separation effect of the water-in-oil emulsion and the oil-in-water emulsion on the components is limited, when the prebiotics are contacted with probiotics, a large amount of consumption of a single component is caused, even the original compounding effect of the component is lost due to the large consumption of the component, the bicontinuous phase emulsion obviously does not have the defects, and even if the loss of part of the components occurs, the loss amount is balanced and small, and the compounding effect is not influenced due to the characteristics of hydrophilic and oleophilic properties and disorder of the two sides of the bicontinuous phase emulsion.
Secondly, the cream is thicker in texture and is suitable for dry skin, so that only a water-in-oil system can be adopted, but according to the ratio of hydrophilic and lipophilic components in the cream, more hydrophilic components in the cream can be found, and the cream is obviously not suitable for the water-in-oil system.
Examples 7 to 13
The prebiotic cream differs from example 1 in the use of the prebiotic composition used, the specific correspondence being shown in the following table.
Table: table comparing usage of prebiotic compositions in examples 7-13
Group of | Prebiotic composition |
Example 7 | From preparation example 20 |
Example 8 | Prepared from preparation 21 |
Example 9 | From preparation 22 |
Example 10 | From preparation 23 |
Examples11 | From preparation 24 |
Example 12 | From preparation 25 |
Example 13 | From preparation 26 |
The prebiotic creams of examples 7-13 were extracted and tested for their skin pest inhibition Δq according to the above-described measurement procedure and measurement criteria, and the average of the test results is reported in the following table.
Table: examples 7 to 13 results of Performance test for skin harmful bacteria inhibition RaQ%
From the above table, it can be seen that the prebiotic creams prepared in examples 1 and 7-13 have excellent effect of improving skin surface microecology, and the purpose that probiotics occupy the dominant position of skin surface microecology can be achieved by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 32.8-34.2%, and the inhibition rate delta Q% of propionibacterium acnes is 41.2-45.3%, which are regarded as having inhibition effect;
The inhibition rate delta Q% of staphylococcus aureus is 61.7-73.3% and the inhibition rate delta Q% of propionibacterium acnes is 79.1-88.8% after being continuously smeared for 30 days, and the composition is considered to have obvious inhibition effect.
Therefore, under the condition that the total dosage of the prebiotic components is certain, the improvement effect on the microecology of the skin surface can be enhanced by adjusting the proportion of each component, and the addition of the functional oligosaccharide, the probiotic components and the plant extract can strengthen the inhibition effect on harmful bacteria by combining the data in the table, and the effect on the performance is less because the components tend to be saturated after reaching a certain amount.
Examples 14 to 15
The prebiotic cream differs from example 1 in the use of the prebiotic composition used, the specific correspondence being shown in the following table.
Table: table comparing usage of prebiotic compositions in examples 14-15
Group of | Prebiotic composition |
Example 14 | From preparation 27 |
Example 15 | From preparation 28 |
The prebiotic creams of examples 14-15 above were extracted and tested for their skin pest inhibition Δq according to the above-described measurement procedure and measurement criteria, and the average of the test results is reported in the following table.
Table: examples 14 to 15 results of Performance test for skin harmful bacteria inhibition RaQ%
From the above table, it can be seen that the prebiotic creams prepared in examples 1 and 14-15 all have excellent effect of improving skin surface microecology, and the purpose that probiotics occupy the dominant position of skin surface microecology can be achieved by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 32.6-33.0%, and the inhibition rate delta Q% of propionibacterium acnes is 41.2-41.5%, which are regarded as having inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 61.4-62.1% and the inhibition rate delta Q% of propionibacterium acnes is 79.1-79.8% after being continuously smeared for 30 days, and the composition is considered to have obvious inhibition effect.
It can be seen that the effect of the selection of the functional oligosaccharides on the actual performance is weak and can be ignored under the condition that the total amount of the prebiotic components and other components are not changed, but the more the types of the functional oligosaccharides, the better the supply effect is, and the growth of the probiotics can be preferably ensured.
In addition, after the emulsion with double continuous phases is prepared, the functions of assisting in forming micro-emulsion can be achieved, the separation and protection functions of the probiotic components are achieved, and meanwhile, the effects of assisting in film forming and moistening protection can be achieved after the emulsion is coated on skin, so that the influence and interference of external adverse factors on probiotics are reduced.
Examples 16 to 19
The prebiotic cream differs from example 1 in the use of the prebiotic composition used, the specific correspondence being shown in the following table.
Table: table for comparing usage of prebiotic compositions in examples 16-19
The prebiotic creams of examples 16-19 above were extracted and tested for their skin pest inhibition Δq according to the above-described measurement procedure and measurement criteria, and the average of the test results is reported in the following table.
Table: examples 16 to 19 results of Performance test for skin harmful bacteria inhibition RaQ%
From the above table, it can be seen that the prebiotic creams prepared in examples 1 and 16-19 all have excellent effect of improving skin surface microecology, and the purpose that probiotics occupy the dominant position of skin surface microecology can be achieved by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 32.8-35.7%, and the inhibition rate delta Q% of propionibacterium acnes is 41.2-48.8%, which are regarded as having inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 61.7-71.0% and the inhibition rate delta Q% of propionibacterium acnes is 79.1-90.1% after being continuously smeared for 30 days, and the composition is considered to have obvious inhibition effect.
The probiotic component compounded by lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and lactobacillus plantarum lysate can be used as an implanted external beneficial bacterium, so that the probiotic can replace harmful bacteria, occupy the dominant position of skin surface microecology, and can also obviously improve the living environment of epidermidis.
In addition, the lactobacillus gasseri and the bifidobacterium animalis are anaerobic bacteria, and enter injury parts such as acne and the like to compete with harmful bacteria under the action of bicontinuous emulsion, so that the propagation and growth environment of the harmful bacteria is destroyed, and the aim of inhibiting pathogens or the fixed value of the harmful bacteria is fulfilled; but not easily influence the reproduction and development of staphylococcus epidermidis in epidermis.
The mixed lactobacillus plantarum lysate can promote growth of lactobacillus rhamnosus of the same genus, inhibit fixed values of pathogens or harmful bacteria, and compound forward implantation of staphylococcus epidermidis, so that the purpose that probiotics replace harmful bacteria and occupy the microecological dominant position on the surface of skin is achieved.
Examples 20 to 27
The prebiotic cream differs from example 16 in the use of the prebiotic composition used, the specific correspondence being shown in the following table.
Table: table for comparing usage of prebiotic compositions in examples 20-27
Group of | Prebiotic composition |
Example 20 | From preparation 33 |
Example 21 | From preparation 34 |
Example 22 | From preparation 35 |
Example 23 | From preparation 36 |
Example 24 | From preparation 37 |
Example 25 | From preparation 38 |
Example 26 | From preparation 39 |
Example 27 | From preparation 40 |
The prebiotic creams of examples 20-27 above were extracted and tested for their skin pest inhibition Δq according to the above-described measurement procedure and measurement criteria, and the average of the test results is reported in the following table.
Table: examples 20 to 27 results of Performance test for skin harmful bacteria inhibition RaQ%
From the above table, it can be seen that the prebiotic creams prepared in examples 16 and 20-27 all have excellent effect of improving skin surface microecology, and the purpose that probiotics occupy the dominant position of skin surface microecology can be achieved by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
the inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 34.8-35.8%, and the inhibition rate delta Q% of propionibacterium acnes is 47.8-48.6%, which are regarded as having inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 68.5-69.1% and the inhibition rate delta Q% of propionibacterium acnes is 86.8-88.1% after being continuously smeared for 30 days, and the composition is regarded as having obvious inhibition effect.
The lactobacillus plantarum lysate prepared by the extraction process has higher retention of beneficial proteins, amino acids and other nutrient substances, and can play a remarkable role in promoting the growth of strains;
in addition, as is apparent from examples 23-26, the culture medium compounded from MRS culture medium, cow's milk and rye beer can effectively increase the protein and amino acid content in the final lysate, and the reason for this analysis may be: the addition of the rye beer can effectively protect the protein containing sulfhydryl groups from being oxidized and part of the protein in the cow milk from being decomposed, so that the activity of the obtained protein and amino acid is higher.
Examples 28 to 36
The prebiotic cream differs from example 1 in the use of the prebiotic composition used, the specific correspondence being shown in the following table.
Table: table comparing usage of prebiotic compositions in examples 28-36
Group of | Prebiotic composition |
Example 28 | From preparation 41 |
Example 29 | From preparation 42 |
Example 30 | From preparation 43 |
Example 31 | From preparation 44 |
Example 32 | From preparation 45 |
Example 33 | From preparation 46 |
Example 34 | From preparation 47 |
Example 35 | From preparation 48 |
Example 36 | From preparation 49 |
Comparative example 5
The prebiotic cream differs from example 1 in that the plant extract used is prepared by the following method:
c1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3 times of volume, performing anaerobic fermentation for 180min at the pH of 5.0 and the temperature of 46 ℃, and performing solid-liquid separation on the fermentation broth, wherein filtrate and filter residues are respectively refrigerated for later use; and C2, placing filter residues obtained in the step C1 into an extracting solution with the volume being 1, adding cellulase accounting for 3 per mill of the extracting solution and pectase accounting for 2 per mill of the extracting solution, continuously carrying out anaerobic fermentation for 12 hours under the conditions of pH 7.0 and the temperature of 40 ℃, carrying out filter pressing for solid-liquid separation, discarding the filter residues, combining the filter residues in the step C1, and carrying out vacuum distillation for water removal to obtain the plant extract.
The prebiotic creams of examples 28-36 and comparative example 5 above were drawn and tested for their skin pest inhibition ΔQ according to the above measurement procedure and measurement criteria, and the average of the test results is reported in the following table.
Table: results of Performance test of skin harmful bacteria inhibition RaQ% of examples 28 to 36, comparative example 5
From the above table, it can be seen that the prebiotic creams prepared in examples 1 and 28-36 have excellent effect of improving skin surface microecology, and the purpose that probiotics occupy the dominant position of skin surface microecology can be achieved by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
The inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 32.4-35.5%, and the inhibition rate delta Q% of propionibacterium acnes is 41.0-47.1%, which are regarded as having inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 61.1-67.8% and the inhibition rate delta Q% of propionibacterium acnes is 78.1-83.6% after being continuously smeared for 30 days, and the composition is considered to have obvious inhibition effect.
The plant extract extracted from the raw material components can be compounded with functional oligosaccharide and probiotics components to improve the microecology on the skin surface, has the epidermis and acne repairing effect and the antibacterial effect, and can effectively destroy the living environment of anaerobic harmful bacteria, so that probiotics are promoted to replace the harmful bacteria rapidly and occupy the dominant position of the microecology on the skin surface, and particularly, the embodiment 1 and the embodiment 28-31 are shown;
the plant extract extracted by the process has high content of effective active substances, can be compounded with functional oligosaccharide and probiotics components to improve the microecology on the skin surface, and can effectively destroy the living environment of anaerobic harmful bacteria; the reasons for analysis may be two, on the one hand, since the C2 extract is a multiphase extract, the respective extraction can be performed for the hydrophilicity and lipophilicity of the effective active substances, see examples 1, 35-36;
The second aspect is that the method adopts a fermentation mode of firstly short-time aerobic and then long-time anaerobic to treat the plant extract, and provides a good decomposition environment for enzymes and additional enzymes of plants, thereby promoting the dissolution of relevant effective components in plant raw materials, and the extraction effect is better than that of direct anaerobic fermentation, as shown in comparative example 5.
Example 37
A prebiotic cream differs from example 1 in that the prebiotic composition used was prepared from preparation 50, i.e. vegetable fat consisted of shea butter, grape seed oil and white pool seed oil in a weight ratio of 1:2:0.5.
Comparative example 6
A prebiotic cream differs from example 1 in that the prebiotic composition used does not contain vegetable fat.
The prebiotic creams of example 37 and comparative example 6 were extracted and tested for their skin pest inhibition Δq according to the above-described measurement procedure and measurement criteria, and the average value of the test results is shown in the following table.
Table: results of Performance test of skin harmful bacteria inhibition RaQ% in example 37 and comparative example 6
As can be seen from the above table, the prebiotic creams prepared in examples 1 and 37 have excellent effect of improving skin surface microecology, and can achieve the purpose that probiotics occupy the dominant position of skin surface microecology by inhibiting harmful bacteria and assisting probiotics to replace harmful bacteria;
The inhibition rate delta Q% of staphylococcus aureus on the day of smearing is 32.8%, and the inhibition rate delta Q% of propionibacterium acnes is 41.2-41.3%, which is regarded as having inhibition effect;
the inhibition rate delta Q% of staphylococcus aureus is 61.7-61.8% and the inhibition rate delta Q% of propionibacterium acnes is 79.1-79.3% after being continuously smeared for 30 days, and the composition is considered to have obvious inhibition effect.
The vegetable oil compounded by the components can assist the formation of a micro-emulsion system of a bicontinuous phase, so that the vegetable oil can stably store functional substances such as functional oligosaccharide, probiotic components, plant extracts and the like, and has certain promotion effects on the epidermis of the plant extracts and the repairing and antibacterial effects of acnes, and the comparison example 6 is provided.
The present embodiment is merely illustrative of the present application and is not intended to be limiting, and those skilled in the art, after having read the present specification, may make modifications to the present embodiment without creative contribution as required, but is protected by patent laws within the scope of the claims of the present application.
Claims (4)
1. A prebiotic facial cream, characterized by comprising a prebiotic composition and a matrix formulation;
the prebiotic composition comprises the following components in parts by weight:
50-60 parts of functional oligosaccharide, 8-12 parts of probiotic components, 8-12 parts of plant extracts, 3-5 parts of emulsification aids, 20-30 parts of deionized water and 15-20 parts of vegetable oil;
the preparation method comprises the following steps:
a1, firstly mixing functional oligosaccharide with deionized water according to corresponding parts by weight, and preheating at 40-60 ℃ to obtain a phase A;
a2, mixing the probiotic components, the plant extracts and the vegetable oil according to the corresponding parts by weight at 30-40 ℃ to obtain a phase B;
a3, after the A, B phase is cooled to room temperature under vacuum condition, mixing A, B phases, adding an emulsifying aid, and finally carrying out ultrasonic mixing to obtain the prebiotic composition;
wherein the probiotic components consist of lactobacillus gasseri, bifidobacterium animalis, staphylococcus epidermidis and lactobacillus plantarum lysate according to the weight ratio of 1 (3-5) (10-20) (8-15);
wherein the plant extract is prepared from the following raw materials in parts by weight:
3-5 parts of red bean pulp, 5-8 parts of haematococcus, 8-15 parts of rehmannia, 5-8 parts of perilla, 3-5 parts of peach petals, 3-5 parts of sesbania and 8-10 parts of radix asparagi;
the extraction method of the plant extract comprises the following steps:
c1, cleaning and crushing the preparation raw materials of the plant extract, placing the plant extract in distilled water with 3-5 times of volume, performing aerobic fermentation at the pH of 5.0-6.0 and the temperature of 46-52 ℃ for 60-120min, and performing solid-liquid separation on fermentation liquor, and respectively refrigerating filtrate and filter residue for later use;
Placing the filter residue obtained in the step C1 into an extracting solution with the volume of 1-2 times, adding cellulase accounting for 2-5%o of the extracting solution and pectase accounting for 1-3%o of the extracting solution, performing anaerobic fermentation for 4-8 hours at the temperature of 40-52 ℃ at the pH of 7-8, performing filter pressing for solid-liquid separation, removing the filter residue, combining the filtrate in the step C1, and performing vacuum distillation for water removal to obtain a plant extract;
wherein the extracting solution in the C2 consists of ethanol, polyglycerol-5 trioleate and ethyl acetate according to the weight ratio of 1 (0.1-0.3) (0.3-0.5);
wherein the vegetable oil is one or more of shea butter, sweet almond oil, grape seed oil, sunflower seed oil, white pool flower seed oil and linseed oil.
2. The prebiotic cream of claim 1 wherein the functional oligosaccharide is one or more of fructo-oligosaccharide, xylo-oligosaccharide, galacto-oligosaccharide, isomalto-oligosaccharide, gentio-oligosaccharide, soy-oligosaccharide and chitosan oligosaccharide.
3. The prebiotic cream of claim 1 wherein the lactobacillus plantarum lysate is extracted by the following method:
b1, inoculating a slant culture of lactobacillus plantarum CCTCC NO: M2017399 into a seed culture medium, namely an MRS culture medium, and culturing for 8-12 hours under the anaerobic condition of 28-32 ℃ to obtain seed liquid;
B2, transferring the seed liquid well grown in the B1 into a fermentation culture medium according to the inoculum size of 0.5-1.2%, and culturing 24-36 h under the same condition of the B1 to obtain a fermentation liquid;
the fermentation culture medium consists of MRS culture medium, cow milk and rye beer in the weight ratio of 1 (0.1-0.3) (0.05-0.10);
b3, centrifuging the fermentation liquor obtained in the step B2 at 8000-12000 rpm for 20-30min, and taking supernatant to obtain lactobacillus plantarum lysate, and freeze-drying at-20 ℃ for later use.
4. A process for the preparation of a prebiotic cream according to any one of claims 1 to 3, characterised by the specific steps of:
vacuum pouring the prebiotic composition and matrix formulation into emulsifying pot, homogenizing at normal temperature for 5-10min to obtain the final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210640211.6A CN114869840B (en) | 2022-06-08 | 2022-06-08 | Prebiotic face cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210640211.6A CN114869840B (en) | 2022-06-08 | 2022-06-08 | Prebiotic face cream and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114869840A CN114869840A (en) | 2022-08-09 |
CN114869840B true CN114869840B (en) | 2023-04-28 |
Family
ID=82680197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210640211.6A Active CN114869840B (en) | 2022-06-08 | 2022-06-08 | Prebiotic face cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114869840B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116077415B (en) * | 2023-02-28 | 2023-12-26 | 广东中科卓原生物科技有限公司 | Ternary probiotic factor composition for regulating skin microecological balance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013122931A2 (en) * | 2012-02-14 | 2013-08-22 | The Procter & Gamble Company | Topical use of a skin-commensal prebiotic agent and compositions containing the same |
CN106361684A (en) * | 2016-08-31 | 2017-02-01 | 广东芭薇生物科技股份有限公司 | Active composition for adjusting microorganism ecological balance of skin surface |
CN109303746B (en) * | 2018-12-13 | 2021-05-28 | 广州环亚化妆品科技有限公司 | Prebiotic composition and preparation method and application thereof |
CN111374896A (en) * | 2018-12-28 | 2020-07-07 | 西安臻瑞生物科技有限公司 | Prebiotics and probiotic skin care product for treating acne and preparation method thereof |
-
2022
- 2022-06-08 CN CN202210640211.6A patent/CN114869840B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN114869840A (en) | 2022-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102578226B (en) | Fermented food containing bifidobacterium bacteria and method for producing the same | |
CN108887674A (en) | A kind of preparation method of lycium ruthenicum composite enzyme liquid | |
KR102006708B1 (en) | Soap composition using wood-cultivated ginseng and soap comprising the same | |
CN111789790B (en) | Whitening emulsion containing rose fermentation liquor and preparation method thereof | |
CN114869840B (en) | Prebiotic face cream and preparation method thereof | |
CN106417607A (en) | Hypsizygus marmoreus polysaccharide aging preventing yogurt and preparation method thereof | |
CN111904909B (en) | Dandruff removing scalp essence containing rose fermentation liquor and preparation method thereof | |
CN108850170A (en) | A kind of red bean Semen Coicis Yoghourt and preparation method thereof | |
KR102262644B1 (en) | Hybrid bacterial cellulose mask sheet having skin microbiome control effect and method for preparing the same | |
CN110283686A (en) | A kind of Chinese pear Chinese medicine compound fruit wine production technology | |
CN105687110A (en) | Plant extract composition for eliminating stretch marks as well as application of composition to cosmetics | |
CN114947119A (en) | Walnut flower fermented food with auxiliary blood sugar and blood fat reducing effect and preparation method thereof | |
CN112522150B (en) | Rice washing water plant fermentation product capable of long-acting removing dandruff and relieving itching and preparation method thereof | |
KR101880470B1 (en) | Cosmetic composition comprising organic acid fermentation and natural polymer for moisturizing effect on the skin | |
CN111789801B (en) | Moisturizing shower gel containing rose fermentation liquor and preparation method thereof | |
KR101797548B1 (en) | Mask pack composition containing velvet-extract | |
CN114317617A (en) | Preparation method and application of triple probiotic fermented compound with anti-wrinkle effect | |
CN113244140A (en) | Composition for regulating skin micro-ecological balance and application and preparation method thereof | |
CN105695196A (en) | Stable rose aromatized wine and preparation method thereof | |
CN111888293B (en) | Moisturizing toner containing rose fermentation liquor and preparation method thereof | |
KR102089538B1 (en) | Komagataeibacter intermedius rb-b-24 and bio cellulose preparing method using the same | |
KR20150054094A (en) | Improvement of dandruff preventing hair loss and hair composition for hair growth | |
CN115381762B (en) | Preparation method of snail fermentation filtrate, composition containing snail fermentation filtrate and application of snail fermentation filtrate | |
CN117717507B (en) | Hair-blacking and hair-loss-preventing essence containing plant extracts and preparation method thereof | |
CN112538444B (en) | Rice washing water fermentation product with scalp oil control and hair softening double-effect functions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Prebiotic face cream and its preparation method Granted publication date: 20230428 Pledgee: Bank of China Limited Suzhou Xiangcheng sub branch Pledgor: CAMPARI SCIENCE & TECHNOLOGY (SUZHOU) CO.,LTD. Registration number: Y2024980003767 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |